Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT and Fiber Supplementation in Obesity and Metabolic Syndrome
NCT03477916Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Apr 2018
- Primary completion
- Jun 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in obesity, metabolic syndrome, sponsored by University of Alberta. Started Apr 2018; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
obesitymetabolic syndrome
Beyond the preview
Go deeper on NCT03477916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03477916.